McKesson to buy Precision Medicine Group in about $2.25 billion deal
McKesson to buy Precision Medicine Group in about $2.25 billion deal Aug 25 (Reuters) - McKesson MCK.N said on Tuesday it would buy clinical research and biopharma commercialization services provider Precision Medicine Group in a deal valued at about $2.25 billion.
(Reporting by Sahil Pandey in Bengaluru; Editing by Jonathan Ananda)
Recent news on McKesson
See all newsCencora to buy American Oncology Network in $2.4 billion deal (updated)
Cencora to buy American Oncology Network in $2.4 billion deal; shares fall
Brief: Mckesson Corp - Declares QTRLY Dividend Of $0.94 Per Share
Option Care Health jumps on $5.8 billion take-private deal
Brief: Option Care Health Co To Pay Onyx Bidco Llc Termination Fee Of $146 Million If Deal Terminated Under Certain Circumstances